Thank you for Subscribing to Life Science Review Weekly Brief
Argenta announces that Dr. George Gunn had been appointed as the company's new Chairman of the Board of Directors.
FREMONT, CA: Argenta, the world's leading CRO and CDMO focused on animal health, has announced that Dr. George Gunn had been appointed as the company's new Chairman of the Board of Directors. He takes over for David Geor, who will continue to represent Argenta's Board of Directors. The change follows the finalization of KKR's acquisition of Argenta earlier this year.
George Gunn, a veterinarian, has worked in the animal health industry for many years. George established Stonehaven Consulting AG in 2015, a global life science consulting company with extensive experience in the animal health industry. Earlier, he worked for Novartis for 12 years, where he was a member of the Executive Committee since 2008. George was President of Pharmacia Animal Health for three years before joining Novartis, and he worked for Johnson & Johnson for 15 years before that. George began his career as a private practice veterinarian and then as a field veterinarian for the United Kingdom Ministry of Agriculture, concentrating on the regulation of zoonotic and economic diseases.
"I am delighted to become Chairman of the Board and to serve Argenta at this important stage in its development. The team has done a good job so far and the strong partnership with KKR enables the company to accelerate its growth strategy, continue to provide high-quality animal health technology as well as services, and build on the vision for Argenta as a global animal health service company," commented George Gunn.
"Georges long history of leadership, experience, and insights in the animal health industry make him an ideal person for this role," said Kugan Sathiyanandarajah, Managing Director at KKR, on behalf of Argenta's shareholders. "I look forward to working closely with him to continue to ensure Argenta makes a positive impact for its customers, its people, and the broader animal health community."
"I would like to thank David Geor for his leadership and the valuable contributions he has made to Argenta. In every interaction throughout the last 12 years, David has led with the best interest of Argenta and its employees firmly in mind, and I am pleased that he continues to be part of our Board," said Ben Russell, CEO of Argenta.